The FDA approves blood test to guide breast cancer therapy by detecting ESR1 mutations for targeted treatment selection.

Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...

Targeted therapies are a type of medicine used to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted ...

Treatments based on genomic profiling can significantly extend survival for patients with advanced or rare cancer, but only ...

A first-in-human clinical trial led by an international team of researchers and published in the New England Journal of ...

SEER 1975–2023 analysis demonstrated a long-term mortality inflection from rising rates to sustained declines, with the ...

Approximately 25-30% of lung cancer patients lack mutations targeted by current therapies, necessitating novel approaches. New targets, including MTAP deletions, SMARC4, and p53 mutations, show ...

An expert discusses how long-term safety considerations are evaluated through clinical trial data and postmarketing surveillance, emphasizing the importance of reporting unexpected adverse events to ...

Oncology patients with metastasized disease in Macomb and Ingham Counties have another, more targeted treatment option at their local Karmanos DETROIT, April 21, 2026 /PRNewswire/ -- The Barbara Ann ...

A new pancreatic cancer drug being tested by doctors in Phoenix is showing promise, potentially doubling survival rates for ...

A Bangalore woman's advanced ovarian cancer treatment transformed after genetic testing revealed a DNA repair deficiency, not ...